Chylomicrons alter the hepatic distribution and cellular response to endotoxin in rats

被引:31
作者
Harris, HW
Rockey, DC
Chau, P
机构
[1] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Surg, San Francisco, CA 94110 USA
[2] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
关键词
D O I
10.1002/hep.510270521
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chylomicrons (CM) can bind endotoxin (lipopolysaccharide [LPS]), forming CM-LPS complexes, and protect against endotoxic shock and death in rodent models of gramnegative sepsis, The liver appears to play a central role in this process, as demonstrated by the increased uptake of LPS by this organ. We examined the effect of CM on the uptake and cellular response to injected I-125-LPS by hepatocytes and hepatic nonparenchymal cells. Whereas CM increased the uptake of LPS by both hepatocytes and Kupffer cells, the increase was proportionately greater in hepatocytes than Kupffer cells. Importantly, CM-LPS complexes inhibited inducible nitric oxide synthase (iNOS) mRNA expression and NO production in Kupffer cells and endothelial cells, reducing mRNA levels by 45% to 50% as compared with LPS alone. CM-bound LPS also reduced NO production by hepatocytes in response to cytokine stimulation. Lastly, CM-LPS complexes yielded a concentration-dependent inhibition of LPS-induced tumor necrosis factor alpha (TNF-alpha) production by Kupffer cells in vitro. These data indicate that the mechanism by which CM protect against endotoxicity may involve an increased uptake of LPS by hepatocytes. Moreover, uptake of CM-bound LPS by liver cells attenuates the capacity of these cells to respond to proinflammatory stimulation. These results highlight important anti-inflammatory properties of CM.
引用
收藏
页码:1341 / 1348
页数:8
相关论文
共 87 条
[1]   EFFICACY AND SAFETY OF MONOCLONAL-ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH SEPSIS SYNDROME - A RANDOMIZED, CONTROLLED, DOUBLE-BLIND, MULTICENTER CLINICAL-TRIAL [J].
ABRAHAM, E ;
WUNDERINK, R ;
SILVERMAN, H ;
PERL, TM ;
NASRAWAY, S ;
LEVY, H ;
BONE, R ;
WENZEL, RP ;
BALK, R ;
ALLRED, R ;
PENNINGTON, JE ;
WHERRY, JC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (12) :934-941
[2]  
ALVAREZ C, 1986, CLIN CHEM, V32, P142
[3]   CONTROL OF CACHECTIN (TUMOR-NECROSIS-FACTOR) SYNTHESIS - MECHANISMS OF ENDOTOXIN RESISTANCE [J].
BEUTLER, B ;
KROCHIN, N ;
MILSARK, IW ;
LUEDKE, C ;
CERAMI, A .
SCIENCE, 1986, 232 (4753) :977-980
[4]   MORPHOLOGY AND FUNCTION OF CELLS OF HUMAN EMBRYONIC LIVER IN MONOLAYER CULTURE [J].
BISSELL, MD ;
TILLES, JG .
JOURNAL OF CELL BIOLOGY, 1971, 50 (01) :222-&
[5]   A CONTROLLED CLINICAL-TRIAL OF HIGH-DOSE METHYLPREDNISOLONE IN THE TREATMENT OF SEVERE SEPSIS AND SEPTIC SHOCK [J].
BONE, RC ;
FISHER, CJ ;
CLEMMER, TP ;
SLOTMAN, GJ ;
METZ, CA ;
BALK, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (11) :653-658
[6]   PROSTANOID PRODUCTION BY LIPOPOLYSACCHARIDE-STIMULATED KUPFFER CELLS [J].
BOWERS, GJ ;
MACVITTIE, TJ ;
HIRSCH, EF ;
CONKLIN, JC ;
NELSON, RD ;
ROETHEL, RJ ;
FINK, MP .
JOURNAL OF SURGICAL RESEARCH, 1985, 38 (05) :501-508
[7]  
CABANA VG, 1989, J LIPID RES, V30, P39
[8]   STRATEGIES FOR BLOCKING THE SYSTEMIC EFFECTS OF CYTOKINES IN THE SEPSIS SYNDROME [J].
CHRISTMAN, JW ;
HOLDEN, EP ;
BLACKWELL, TS .
CRITICAL CARE MEDICINE, 1995, 23 (05) :955-963
[9]   MULTIPLE CYTOKINES ARE REQUIRED TO INDUCE HEPATOCYTE NITRIC-OXIDE PRODUCTION AND INHIBIT TOTAL PROTEIN-SYNTHESIS [J].
CURRAN, RD ;
BILLIAR, TR ;
STUEHR, DJ ;
OCHOA, JB ;
HARBRECHT, BG ;
FLINT, SG ;
SIMMONS, RL .
ANNALS OF SURGERY, 1990, 212 (04) :462-471
[10]   PATTERNS OF CYTOKINES, PLASMA ENDOTOXIN, PLASMINOGEN-ACTIVATOR INHIBITOR, AND ACUTE-PHASE PROTEINS DURING THE TREATMENT OF SEVERE SEPSIS IN HUMANS [J].
DOFFERHOFF, ASM ;
BOM, VJJ ;
DEVRIESHOSPERS, HG ;
VANINGEN, J ;
VANDERMEER, J ;
HAZENBERG, BPC ;
MULDER, POM ;
WEITS, J .
CRITICAL CARE MEDICINE, 1992, 20 (02) :185-192